See also
Cia-dependent small RNAs
Quellung reaction
Streptococcal infection in poultry
Streptococcal pharyngitis
Streptokinase

References
External links
Centers for Disease Control Prevention (CDC) (March 2000). "Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers—Connecticut and Minnesota, 1998". MMWR Morb. Mortal. Wkly. Rep. 49 (11): 228–32. PMID 10763673. Nature-Inspired CRISPR Enzyme Discoveries Vastly Expand Genome Editing . On: SciTechDaily. June 16, 2020. Source: Media Lab, Massachusetts Institute of Technology. Streptococcus genomes and related information at PATRIC, a Bioinformatics Resource Center funded by NIAID
The Canadian Strep B Foundation Archived 2013-05-02 at the Wayback Machine
The UK Group B Strep Support charity
Quinidine is a class IA antiarrhythmic agent used to treat heart rhythm disturbances. It is a stereoisomer of antimalarial agent quinine, originally derived from the bark of the cinchona tree. The drug causes increased action potential duration, as well as a prolonged QT interval. As of 2019 its IV formulation is no longer being manufactured for use in the United States. Medical uses
Quinidine is occasionally used as a class I antiarrhythmic agent to prevent ventricular arrhythmias, particularly in Brugada Syndrome, although its safety in this indication is uncertain.It reduces the recurrence of atrial fibrillation after patients undergo cardioversion, but it has proarrhythmic effects and trials suggest that it may lead to an overall increased mortality in these patients.Quinidine is also used to treat short QT syndrome.Eli Lilly has discontinued manufacture of parenteral quinidine gluconate in the US, and its future availability in many countries is uncertain. Other uses
There is one study supporting the use of a novel combination of dextromethorphan and low dose quinidine in alleviating symptoms of easy laughing and crying (pseudobulbar affect); these are a type rather severe uncontrollable behaviors which can be present in various neurological pathologies such as amyotrophic lateral sclerosis and multiple sclerosis. The dose of quinidine (10mg two times daily) is about 1/40th of a relatively low antiarrhythmic dose (400mg, twice or 3 times daily, as an example; antiarrhythmic doses can sometimes exceed 1500mg/day).